References

  1. Albright F, Butler AM, Bloomberg E. Rickets resistant to vitamin D therapy. Am J Dis Child. 1937; 54(3): 529-547. Google Scholar

  2. Carpenter TO. New perspectives on the biology and treatment of X-linked hypophosphatemic rickets. Pediatr Clin North Am. 1997; 44(2): 443-466. PubMed | Google Scholar

  3. Rasmussen H, Tenenhouse HS. Mendelian hypophosphatemias: the molecular and metabolic basis of inherited diseases. 1994-7th edition.

  4. Rowe PS, Goulding J, Read A et al. New markets for linkage analysis of X-linked hypophosphatemic tickets. Hum Gene. 1993; 91(6): 571-575. PubMed | Google Scholar

  5. Rosenberg LE. In born errors of metabolism. Saunders Duncan's Diseases of Metabolism. 1974; 8: 53. Google Scholar

  6. Pronicka E, Popowska E, Rowinska E and al. Biochemical and DNA markers of X-linked hypophosphatemic rickets: a study of sporadic cases. J Inher Metab Dis. 1992; 15(3): 335-8. PubMed | Google Scholar

  7. HYP Consonium. A gene (PEX) with homologies to endopeptidases in mutated in patient s with X-linked hypophosphatemic rickets. Nat Genet. 1995; 11(2): 130-136. PubMed | Google Scholar

  8. Maladies génétiques avec troubles du métabolisme phosphocalcique. Revue du rhumatisme monographies. 2012; 79(4): 262-268. Google Scholar

  9. Witcop CJ. Manifestations of genetic diseases in the human pulp. Oral Surg Oral Med Oral Pathol. 1971; 32(2): 278-316. PubMed | Google Scholar

  10. Friedman NE, Lobaugh, Drezner MK. Effets of calcitriol and phosphorus therapy on the growth or patients with X-linked hypophosphatemia. J Clin Endocrinol Metab. 1993; 76(4): 839-844. PubMed | Google Scholar

  11. Balsan S, Tieder M. Linear growth in patients with hypophosphatemic vitamin D resistant rickets: influence of treatment regimen and parental height. J Pediatr. 1990; 116(3): 365-371. PubMed | Google Scholar

  12. Saggese G, Baron Celli GI, Barsanti S. Traitement par hormones de croissance du rachitisme hypophosphatémique familial. Arch Pediatr. 1998; 5 (suppl 4): 360-363. Google Scholar

  13. Aono Y, Hasegawa H, Yamazaki Y al. Anti-FGF-23 neutralizing antibodies ameliorate muscle weakness and decreased spontaneous movement in HYP mice. J Bone Miner Res. 2011; 26(4): 803-10. PubMed | Google Scholar

  14. Cohen S, Becker GL. Origin, diagnosis and treatment of dental manifestations of vitamin D-resistant rickets: review of the literature and report of case. JADA. 1976; 92(1): 120-129. PubMed | Google Scholar